Evidence map›Paper›PMID 27635232›Full record

ArticleF1000Research2016

Top 10 metrics for life science software good practices.

Haydee Artaza, Neil Chue Hong, Manuel Corpas, Angel Corpuz, Rob Hooft, Rafael C Jimenez, Brane Leskošek, Brett G Olivier, Jan Stourac, Radka Svobodová Vařeková and 2 more

Abstract read
In one paragraph

Article in F1000Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haydee Artaza *The Earlham Institute & ELIXIR-UK, Norwich Research Park, Norwich, NR4 7UH, UK.
Neil Chue Hong *Software Sustainability Institute, University of Edinburgh, Edinburgh, EH9 3FD, UK.
Manuel Corpas *The Earlham Institute & ELIXIR-UK, Norwich Research Park, Norwich, NR4 7UH, UK.
Angel Corpuz *University "La Sapienza, Rome, 00185, Italy.
Rob Hooft *DTL, PO Box 19245, Utrecht, 3501 DE, Netherlands.
Rafael C Jimenez *ELIXIR Hub, Wellcome Trust Genome Campus, Hinxton, CB10 1SD, UK.
Brane Leskošek *Institute for Biostatistics and Medical Informatics (IBMI), Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1104, Slovenia.
Brett G Olivier *Systems Bioinformatics, Vrije Universiteit Amsterdam, Amsterdam, 1081 HV, Netherlands.
Jan Stourac *Loschmidt Laboratories, Faculty of Science, Masaryk University, Brno, 625 00, Czech Republic.
Radka Svobodová Vařeková *CEITEC Masaryk University, Brno, 625 00, Czech Republic.
Thomas Van Parys *Department of Plant Systems Biology, VIB, Ghent, 9052, Belgium.
Daniel Vaughan *EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, CB10 1SD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metrics for assessing adoption of good development practices are a useful way to ensure that software is sustainable, reusable and functional. Sustainability means that the software used today will be available - and continue to be improved and supported - in the future. We report here an initial set of metrics that measure good practices in software development. This initiative differs from previously developed efforts in being a community-driven grassroots approach where experts from different organisations propose good software practices that have reasonable potential to be adopted by the communities they represent. We not only focus our efforts on understanding and prioritising good practices, we assess their feasibility for implementation and publish them here.

Indexed as

ELIXIREvaluationImpactMetricsSoftware, Best PracticesSustainability

Identifiers

PMID27635232
PMCPMC5007752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.